Clinical Study on Anti-tumor Effect Induced by Activated Primary Natural Killer（NK）Cells
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Pancreatic Cancer
Related studies linked through entity extraction aliases.
Second-line Study of PEGPH20 and Pembro for HA High Metastatic PDAC
- Status
- UNKNOWN
- Phase
- PHASE2
Monitoring of patIents With Microdialysis Following Pancreaticoduodenectomy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Early Detection of Anastomotic Leakage by Microdialysis Catheters
- Status
- COMPLETED
- Phase
- N/A
RCT of Mobile Apps & FitBit v. Usual Care
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Stereotactic MRI-guided On-table Adaptive Radiation Therapy (SMART) for Locally Advanced Pancreatic Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Ablation of Unresectable Locally Advanced Pancreatic Cancer With Irreversible Electroporation (IRE) System
- Status
- COMPLETED
- Phase
- N/A
SurePathTM Liquid-based Cytology and Conventional Smear Cytology in Pancreatic Lesions
- Status
- UNKNOWN
- Phase
- N/A
Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Niraparib in Patients With Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Folfirinox or Gemcitabine-Nab Paclitaxel Followed by Stereotactic Body Radiotherapy for Locally Advanced Pancreatic Cancer
- Status
- TERMINATED
- Phase
- EARLY_PHASE1
Study of Nivolumab, Cabiralizumab, and Stereotactic Body Radiotherapy (SBRT) for Locally Advanced Unresectable Pancreatic Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Evaluation of GEMCITEST in Patients With Pancreatic Cancer and Treated by Chemotherapy
- Status
- COMPLETED
- Phase
- N/A
QUILT-3.080: NANT Pancreatic Cancer Vaccine
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Trial of Neoadjuvant Chemotherapy With S1 Plus Paclitaxel-albumin on Pancreatic Cancer
- Status
- TERMINATED
- Phase
- PHASE2
GEN1029 (HexaBody®-DR5/DR5) Safety Trial in Patients With Malignant Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Neoadjuvant CCRT With Gemcitabine/Durvalumab (MEDI4736) Followed by Adjuvant Gemcitabine/Durvalumab(MEDI4736) in Resectable or Borderline Resectable Pancreatic Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Losartan and Nivolumab in Combination With FOLFIRINOX and SBRT in Localized Pancreatic Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Niraparib in Metastatic Pancreatic Cancer After Previous Chemotherapy (NIRA-PANC): a Phase 2 Trial
- Status
- UNKNOWN
- Phase
- PHASE2